Nokia Bell Labs Shannon Luminary Lecture - The Future of Human Agency - Dr. Stephen Friend
In honor of Claude Shannon – the father of information theory and arguably of all communications and networked systems – Bell Labs has created the Shannon Luminary Lecture Series and Award, to explore all topics of high impact and relevance to the future of human existence, with an annual series of ten talks by the leading visionary researchers, developers, thinkers and entrepreneurs from all fields of scientific, technological, engineering, mathematical, or related artistic endeavor.
The May 2017 lecture will be given by Dr. Stephen Friend, scientist, physician, entrepreneur, Chairman of Sage Bionetworks and member of the Apple Health team. In his career, he has played a major part in understanding how gene expression affects health and disease, from the first discovery of a cancer susceptibility gene in the 1980s to the launch of a vast collaboration of researchers to greatly accelerate genetics research, aiming to tackle diseases at a fundamental level.
Dr. Friend will present “The Future of Human Agency - Exploration of the Role of Art and Technology in Determining Risk, Awareness and Free Will". The presentation will be held in the Hamming Innovation Hall on the Murray Hill Bell Labs Campus.
Prior awardees include Eric Schmidt, Irwin Jacobs, Bob Metcalfe, Amber Case, Henry Markram, Zhenan Bao, Yann LeCun, and David Eagleman.
As space is limited, please confirm your attendance as soon as possible. Registration will close as soon as the capacity of the Hamming Innovation Hall has been reached, or, at the latest, by April 27.
If you are unable to attend after you have registered then please contact info@bell-labs.com with a copy to avw@ieee.org, to cancel such that seats can be made available to others.
This event is co-sponsored by the IEEE North Jersey Section and its IEEE Information Theory Society Chapter.
Date and Time
Location
Hosts
Registration
- Date: 04 May 2017
- Time: 02:00 PM to 03:30 PM
- All times are (GMT-05:00) US/Eastern
-
Add Event to Calendar
- 600 Mountain Ave, Murray Hill, NJ
- Murray Hill, New Jersey
- United States 07974
- Building: Bell Laboratories, Nokia, Hamming Innovation Hall
- Contact Event Host
-
Adriaan J. van Wijngaarden, Junior Past-Chair, IEEE North Jersey Section (avw@ieee.org)
Chair, IEEE North Jersey/New York Information Theory Chapter - Co-sponsored by IT, COMSOC, VTS
Speakers
Dr. Stephen Friend
The Future of Human Agency
This presentation will provide a perspective on the roles of art and technology in understanding risk and consequences of a future in which artificial intelligence, along with massive crowd-sourced data, will reveal novel insights empowering our choices, and posing potential dilemmas.
Biography:
Dr. Friend is the Chairman of the Board and Past-President of Sage Bionetworks, a non-profit organization that provides the tools and environment to conduct dynamic, large-scale collaborative biomedical research. He is an authority in the field of cancer biology and a pioneer in the field of the genetics of gene expression, integrating system biology approaches to complex diseases. Dr. Friend co-founded Sage Bionetworks in 2009 on the belief that successful biomedical research requires the active participation of all stakeholders. Through Sage Bionetworks, he has worked to reimagine the role of citizens in the research process and to build the tools to empower citizens to contribute both their data and expertise as they see fit. Under his leadership, Sage Bionetworks has developed an open-source technology platform, called Synapse, for data-intensive analysis, sharing and reuse, enabling researchers to perform cutting edge computational biology and research by iteratively generating and testing novel hypotheses transparently and collaboratively. Sage Bionetworks has engaged the community to crowd-source solutions to complex biomedical questions through targeted DREAM challenges, and has expanded efforts in patient centered research through its mobile health initiatives.
Dr. Friend is currently in a full time role at Apple Inc. where he works on ways to impact people’s lives in health and disease. Prior to co-founding and leading Sage as President, Dr. Friend was Senior Vice President and Franchise Head for Oncology Research at Merck & Co., Inc. where he led Merck’s Basic Cancer Research efforts. Formerly Dr. Friend along with Dr. Hartwell founded and co-led the Fred Hutchinson Cancer Research Center’s “Seattle Project”, an advanced institute for drug discovery and later they co-founded Rosetta Inpharmatics with Drs Hartwell and Hood. Dr. Friend also held faculty positions at Harvard Medical School from 1987 to 1995 and at Massachusetts General Hospital from 1990 to 1995. He received his M.D/Ph.D. from Indiana University. Dr. Friend was named an Ashoka Fellow for his work at Sage Bionetworks.
Agenda
| 14:00-15:30 | The Future of Human Agency |
| Dr. Stephen Friend |